Intercellular adhesion molecule-1 expression in endothelial cells is activated by cytomegalovirus immediate early proteins

Transplantation

Volumn 67, Issue 1, 1999, Pages 137-144

  Burns, Linda J ^a,b   Pooley, Joan C ^a   Walsh, Daniel J ^a   Vercellotti, Gregory M ^a   Weber, Marc L ^a   Kovacs, Andras ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; MESSENGER RNA; VIRUS PROTEIN;

ARTICLE; BLOOD VESSEL INJURY; CELL CULTURE; DNA FLANKING REGION; ENDOTHELIUM CELL; GENE ACTIVATION; GENE EXPRESSION; GENE SEQUENCE; GRAFT REJECTION; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; PRIORITY JOURNAL; REGULATORY MECHANISM; TRANSACTIVATION; UMBILICAL VEIN; VIRUS INFECTION;

EID: 0033556466     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199901150-00023     Document Type: Article

References (55)

1. Gratten MT, Moreno-Cabral CE, Starnes VA, Oyer P, Stinson EB, Shumway NE. Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis. JAMA 1989; 261: 3561.
2. McDonald K, Rector TS, Braunlin EA, Kubo S, Olivari MT. Association of coronary artery disease in cardiac transplant recipients with cytomegalovirus infection. Am J Cardiol 1989; 64 :359.
3. Kendall TJ, Wilson JE, Radio SJ, et al. Cytomegalovirus and other herpes viruses: do they have a role in the development of accelerated coronary arterial disease in human heart allografts? J Heart Lung Transplant 1992; 11:S14.
4. Hosenpud JD, Shipley GD, Wagner CR. Cardiac allograft vasculopathy: current concepts, recent developments, and future directions. J Heart Lung Transplant 1992; 11: 9.
5. Steinhoff G, You XM, Steinmuller C, et al. Induction of endothelial adhesion molecules by rat cytomegalovirus in allogeneic lung transplantation in the rat. Scand J Infect Dis Suppl 1995; 99: 58.
6. Fuggle SV, Sanderson JB, Gray DWR, Richardson A, Morris PJ. Variation in expression of endothelial adhesion molecules in pretransplant and transplanted kidneys-correlation with intragraft events. Transplantation 1993; 55: 117.
7. Scholz M, Hamann A, Blaheta RA, Auth MKH, Encke A, Markus BH. Cytomegalovirus-and Interferon-related effects on human endothelial cells. Cytomegalovirus infection reduces upregulation of HLA class II antigen expression after treatment with interferon-γ. Hum Immunol 1992; 35: 230.
8. Sedmak DD, Knight DA, Vook NC, Waldman JW. Divergent patterns of ELAM-1, ICAM-1, and VCAM-1 expression on CMV-infected endothelial cells. Transplantation 1994; 58: 1379.
9. Voraberger G, Schafer R, Stratowa C. Cloning of the human gene for intercellular adhesion molecule 1 and analysis of its 5′-regulatory region: induction by cytokines and phorbol ester. J Immunol 1992.; 147: 2777.
10. Cornelius LA, Taylor JT, Degitz K, Li L-J, Lawley TJ, Caughman SW. A 5′ portion of the ICAM-1 gene confers tissue-specific differential expression levels and cytokine responsiveness. J Invest Dermatol 1993; 100: 753.
11. Ledebur HC, Parks TP. Transcriptional regulation of the intercellular adhesion molecule-1 by inflammatory cytokines in human endothelial cells. J Biol Chem 1995; 270: 933.
12. Suzuki Y, Tanigaki T, Heimer D, et al. TGF-β1 causes increased endothelial ICAM-1 expression and lung injury. J Appl Physiol 1994; 77: 1281.
13. Hou J, Baichwal V, Cao Z. Regulatory elements and transcription factors controlling basal and cytokine-induced expression of the gene encoding intercellular adhesion molecule 1. Proc Natl Acad Sci USA 1994; 91: 11641.
14. Caldenhoven E, Coffer P, Yuan J, et al. Stimulation of the human intercellular adhesion molecule-1 promoter by interleukin-6 and interferon-y involves binding of distinct factors to a palindromic response element. J Biol Chem 1994; 269: 21146.
15. Stinski MF, Thomsen DR, Stenberg RM, Goldstein LC. Organization and expression of the immediate early genes of human cytomegalovirus. J Virol 1983; 46: 1.
16. Stenberg RM, Witte PR, Stinski MF. Multiple spliced and unspliced transcripts from human cytomegalovirus immediate-early region 2 and evidence for a common initiation site within immediate-early region 1. J Virol 1985; 56: 665.
17. Stinski MF. Cytomegalovirus and its replication. In: Fields BN, Knipe DM, eds. Virology. New York: Raven Press, 1990; 1959.
18. Stamminger T, Fleckenstein B. Immediate-early transcription regulation of human cytomegalovirus. In: McDougall JK, ed. Cytomegaloviruses. New York: Springer-Verlag, 1990; 3.
19. Nelson JA, Gnann JW Jr, Ghazal P. Regulation and tissue-specific expression of human cytomegalovirus. In: McDougall JK, ed. Cytomegaloviruses. New York: Springer-Verlag, 1990; 75.
20. Stinski MF, Malone Cl, Hermiston TS, Liu B. Regulation of human cytomegalovirus transcription. In: Wagner EK, ed. Herpes-virus transcription and its regulation. Boca Raton, FL: CRC Press, 1991; 246.
21. Burns LJ, Waring JF, Reuter JJ, Ginder GD. Only the HLA class I gene minimal promoter elements are required for transactivation by human cytomegalovirus immediate early genes. Blood 1993; 81: 1558.
22. Hagemeier C, Walker SM, Sissons PJG, Sinclair JH. The 72K IE1 and 80K IE2 proteins of human cytomegalovirus independently trans-activate the c-fos, c-myc and hsp 70 promoters via basal promoter elements. J Gen Virol 1992; 73: 2385.
23. Crump JW, Geist LJ, Auron PE, Webb AC, Stinski MF, Hunninghake GH. The immediate early genes of human cytomegalovirus require only proximal promoter elements to up-regulate expression of interleukin-1β. Am J Respir Cell Mol Biol 1992; 6: 674.
24. Ghazal P, Young J, Giuliette E, et al. A discrete cis element in the human immunodeficiency virus long terminal repeat mediates synergistic trans activation by cytomegalovirus immediate-early proteins. J Virol 1991; 65: 6735.
25. Walker S, Hagemeier C, Sissons JG, Sinclair JH. A 10-base-pair element of the human immunodeficiency virus type 1 long terminal repeat (LTR) is an absolute requirement for transactivation by the human cytomegalovirus 72-kilodalton IE1 protein but can be compensated for by other LTR regions in transactivation by the 80-kilodalton IE2 protein. J Virol 1992; 66: 1543.
26. Hagemeier C, Walker S, Caswell R, Kouzarides T, Sinclair JH. The human cytomegalovirus 80-kilodalton but not the 72-kilodalton IE protein transactivates heterologous promoters in a TATA box-dependent mechanism and interacts directly with TFIID. J Virol 1992; 66: 4452.
27. Yurochko AD, Kowalik TF, Huong SM, Huang ES. Human cytomegalovirus up-regulates NF-kappa B activity by transactivating the NF-kappa B p105/p50 and p65 promoters. J Virol 1995; 69: 5391.
28. Koffraon AJ, Mueller KH, Kaufman DB, Stuart FP, Patterson B, Abecassis MI. Direct evidence using in situ polymerase chain reaction that the endothelial cell and T-lymphocyte harbor latent murine cytomegalovirus. Scand J Infect Dis Suppl 1995; 99: 61.
29. Fish KN, Stenglein SG, Ibanez C, Nelson JA. Cytomegalovirus persistence in macrophages and endothelial cells. Scand J Infect Dis Suppl 1995; 99: 34.
30. Jaffe EA, Nachman RL, Becker CG, Minick CR. Culture of human endothelial cells derived from umbilical veins. J Clin Invest 1973; 52: 2745.
31. Waldman WJ, Sneddon JM, Stephens RE, Roberts WH. Enhanced endothelial cytopathogenicity induced by a cytomegalovirus strain propagated in endothelial cells. J Med Virol 1989; 28: 223.
32. Kovacs A, Weber ML, Burns LJ, Jacob HS, Vercellotti GM. Cytoplasmic sequestration of p53 in cytomegalovirus-infected human endothelial cells. Am J Pathol 1996; 149: 1531.
33. Thomas PS. Hybridization to denatured RNA transferred or dotted to nitrocellulose paper. Methods Enzymol 1983; 100: 255.
34. Gunning P, Ponte P, Okayama H, Engel J, Blau H, Kedes L. Isolation and characterization of full length cDNA clones for human α-, β-and γ-actin mRNA: skeletal but not cytoplasmic actins have an amino-terminal cysteine that is subsequently removed. Mol Cell Biol 1983; 3: 787.
35. Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, Struhl K, eds. Current protocols in molecular biology. New York: John Wiley & Sons Inc., 1992.
36. Sanger F, Nicklen S, Coulson AR. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 1983; 74: 5463.
37. Horton RM, Hunt HD, Ho SN, Pullen JK, Pease LR. Engineering hybrid genes without the use of restriction enzymes: gene splicing by overlap extension. Gene 1989; 77: 61.
38. Hermiston TS, Malone CL, Witte PR, Stinski MF. Identification and characterization of the human cytomegalovirus immediate-early region 2 gene that stimulates gene expression from an inducible promoter. J Virol 1987; 61: 3214.
39. Abken H, Reifenrath B. A procedure to standardize CAT reporter gene assay. Nucleic Acids Res 1992; 20: 3527.
40. Wertheimer SJ, Myers CL, Wallace RW, Parks TP. Intercellular adhesion molecule-1 gene expression in human endothelial cells. J Biol Chem 1992; 267: 12030.
41. Geist LJ, Monick MM, Stinski MF, Hunninghake GH. The immediate early genes of human cytomegalovirus up-regulate tumor necrosis factor-a gene expression. J Clin Invest 1994; 93: 474.
42. Almeida GD, Porada CD, St Jeor S, Ascensao JL. Human cytomegalovirus alters interleukin-6 production by endothelial cells. Blood 1994; 83: 370.
43. Michelson S, Alcami J, Kim S-J, et al. Human cytomegalovirus infection induces transcription and secretion of transforming growth factor β1. J Virol 1994; 68: 5730.
44. Craigen JL, Grundy GE. Cytomegalovirus induced up-regulation of LFA-3 (CD58) and ICAM-1 (CD54) is a direct viral effect that is not prevented by ganciclovir or foscarnet treatment. Transplantation 1996; 62: 1102.
45. Sambucetti LC, Cherrington JM, Wilkinson GW, Mocarski ES. NF-KB activation of the cytomegalovirus enhancer is mediated by a viral transactivator and by T cell stimulation. EMBO J 1989; 8: 4251.
46. Arlt H, Lang D, Gebert S, Stamminger T. Identification of binding sites for the 86-kilodalton IE2 protein of human cytomegalovirus within an IE2-responsive viral early promoter. J Virol 1994; 68: 4117.
47. Jupp R, Hoffmann S, Depto A, Stenberg RM, Ghazal P, Nelson JA. Direct interaction of the human cytomegalovirus IE86 protein with the cis repression signal does not preclude TBP from binding to the TATA box. J Virol 1993; 67: 5595.
48. Lang D, Stamminger T. The 86-kilodalton IE-2 protein of human cytomegalovirus is a sequence-specific DNA-binding protein that interacts directly with the negative autoregulatory response element located near the cap site of the IE-1/2 enhancer-promoter. J Virol 1993; 67: 323.
49. Macias MP, Stinski MF. An in vitro system for human cytomegalovirus IE2-mediated site-dependent repression of transcription and direct binding of IE2 to the major immediate early promoter. Proc Natl Acad Sci USA 1993; 80: 707.
50. Caswell R, Hagemeier C, Chiou CJ, Hayward G, Kouzarides T, Sinclair J The human cytomegalovirus 86K immediate early (IE) 2 protein requires the basic region of the TATA-box binding protein (TBP) for binding, and interacts with TBP and transcription factor TFIIB via regions of IE2 required for transcriptional regulation. J Gen Virol 1993; 74: 2691.
51. Furnari BA, Poma E, Kowalik TF, Huong S-M, Huang E-S. Human cytomegalovirus immediate-early gene 2 protein interacts with itself and with several novel cellular proteins. J Virol 1993; 67: 4981.
52. Jupp R, Hoffman S, Stenberg RM, Nelson JA, Ghazal P. Human cytomegalovirus IE86 protein interacts with promoter-bound TATA-binding protein via a specific region distinct from the autorepression domain. J Virol 1993; 67: 7539.
53. Lukac DM, Manuppello JR, Alwine JC. Transcriptional activation by the human cytomegalovirus immediate-early proteins: requirements for simple promoter structures and interactions with multiple components of the transcription complex. J Virol 1994; 68: 5184.
54. Lang D, Gebert S, Arlt H, Stamminger T. Functional interaction between the human cytomegalovirus 86-kilodalton IE2 protein and the cellular transcription factor CREB. J Virol 1995; 69: 6030.
55. Huang L, Malone CL, Stinski MF. Human cytomegalovirus early promoter with upstream negative and positive cis-acting elements: IE2 negates the effect of the negative element, and NF-Y binds to the positive element. J Virol 1994; 68: 2108.